Preclinical safety testing of monoclonal antibodies: the significance of species relevance

Chapman, Kathryn, Pullen, Nick, Graham, Mark, Ragan, Ian·2007·Nature Reviews Drug Discovery
DOI 10.1038/nrd2242

Cited by (121)

Items 101–121 of 121

  1. Nonclinical Safety Assessment of Biologics, Including Vaccines
    Liangbiao George Hu, David W. Clarke · 2013 · Pharmaceutical Sciences Encyclopedia
  2. Drugs for Cancer
    James F. Spicer, Johann Sebastian De Bono · 2013
  3. Nonclinical Safety Assessment of Biotechnology‐Derived Products: Considerations and Challenges
    Barbara J. Mounho · 2014
  4. Toxicological Considerations for Pharmaceutical Products
    Lynnda L. Reid · 2009 · General, Applied and Systems Toxicology
  5. Drug Development Strategies for Therapeutic Biologics: Industry Perspectives
    Theresa M. Yuraszeck, Megan A. Gibbs · 2015 · Wiley eBooks
  6. Significance of species and study design in pre-clinical testing of biologics: challenges and opportunities
    Kathryn L. Chapman · 2013 · Toxicology Letters
  7. Nonhuman primates in preclinical research
    Adam D. Aulbach, Daniel J. Patrick, Ali Said Faqi · 2014 · Elsevier eBooks
  8. Nonclinical Safety Evaluation of Drugs
    Thomas M. Monticello, Jeanine L. Bussiere · 2018 · CRC Press eBooks
  9. Translational Considerations and Challenges: An Overview
    Vaishnavi Ganti, Mohammad A. Tabrizi · 2018 · Springer eBooks
  10. A Primate as an Animal Model for Reproductive and Developmental Toxicology Testing
    Ali Said Faqi · 2017 · Elsevier eBooks
  11. Preclinical toxicological evaluation of measles virus vaccine strain in non-human primates: A two-month intravenous study
    Dang Thanh Chung, Ho Thi Long, Hoang Văn Tong, Ngo Thu Hang, Ngô Thu Hường, Bui Khac Cuong, Pham Van Tran, Nguyễn Thùy Linh, Nguyễn Đăng Hiền, Cấn Văn Mão et al. · 2021 · Biomedical Research and Therapy
  12. Nonclinical Safety Evaluation of Drugs
    Thomas M. Monticello, Jeanine Bussiere · 2013 · CRC Press eBooks
  13. Nonhuman Primates in Preclinical Research
    Adam D. Aulbach, Daniel J. Patrick · 2019 · Elsevier eBooks
  14. Developmental and reproductive safety assessment of biopharmaceuticals
    Christopher Bowman, Pauline L. Martin · 2011 · Informa Healthcare eBooks
  15. An Unexpected Symbiosis of Animal Welfare and Clinical Relevance in a Refined Nonhuman Primate Model of Human Autoimmune Disease
    Bert A. ‘t Hart, Jon D. Laman, Yolanda S. Kap · 2023 · Springer eBooks
  16. InVivoMethods for Oral Bioavailability Studies
    Ana Ruiz-Garcı́a, Marival Bermejo · 2023
  17. Preclinical Development of Nononcogenic Drugs (Small and Large Molecules)
    John B. Colerangle · 2024 · Elsevier eBooks
  18. Multiple Sclerosis: Current Knowledge of the Pathology and Use of Monoclonal Antibodies as a Promising Therapy
    Josué Castellón-Arias, Luana Gazel-Meléndez, Rebeca Guido-Villalobos, Ariela Jiménez-Díaz, Johana Valera-Rangel, Juan José Mora Román · 2023 · Borneo Journal of Pharmacy
  19. Pharmacokinetics of Therapeutic Antibodies and Derivatives
    Emile P. Chen · 2025 · Wiley eBooks
  20. Regulatory‐Driven Pharmacokinetic and Immunogenicity Study of Siltartoxatug, a Recombinant Native Human Monoclonal Antibody Against Tetanus Toxin, in Cynomolgus Monkeys
    Xia Zhou, Fei Zhou, Zhenpeng Fu, Weijun Ye, Guo Li, Jason Li, Weihong Zheng, Hua‐Xin Liao, Shaojie Wang, Xiaoyi Liu · 2026 · Advances in Pharmacological and Pharmaceutical Sciences
  21. Studies on nStudies on neutralizing anti-heparin-binding epidermal growth factor-like growth factor (HB-EGF) antibodies for drug development of cancer treatment
    Shuji Sato · 2013 · Institutional Repositories DataBase (IRDB)